Here is the latest shareholding Pattern of FREDUN PHARMA. For more details, see the FREDUN PHARMA financial fact sheet and FREDUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 51.04 | 51.04 | 50.34 | 50.15 | 49.62 | 49.31 | 49.16 | 49.13 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 51.04 | 51.04 | 50.34 | 50.15 | 49.62 | 49.31 | 49.16 | 49.13 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 1.68 | 1.68 | 1.66 | 1.65 | 1.64 | 1.60 | 1.60 | 1.60 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 1.68 | 1.68 | 1.66 | 1.65 | 1.64 | 1.60 | 1.60 | 1.60 | |
Bodies Corporate | % | 1.35 | 1.22 | 1.14 | 0.81 | 0.78 | 0.80 | 0.70 | 0.70 | |
Individuals | % | 42.06 | 42.08 | 42.48 | 43.07 | 43.60 | 43.48 | 43.67 | 43.70 | |
NRIs/OCBs | % | 2.85 | 2.79 | 2.77 | 2.69 | 2.68 | 2.58 | 2.58 | 2.58 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.01 | 1.18 | 1.61 | 1.63 | 1.68 | 2.23 | 2.30 | 2.30 | |
Total Non-Institution | % | 47.27 | 47.27 | 48.00 | 48.20 | 48.74 | 49.09 | 49.25 | 49.28 | |
Total Public | % | 49.00 | 49.00 | 50.00 | 50.00 | 50.00 | 51.00 | 51.00 | 51.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.